End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.19 CNY | +0.29% | +2.20% | -3.36% |
05-07 | US FDA Grants Clinical Trial Approval for Fosun Unit's Gastric Cancer Tablets | MT |
04-30 | Fosun Pharma's Q1 Profit Slumps 38% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.36% | 8B | |
+33.43% | 690B | |
+26.43% | 546B | |
-5.12% | 358B | |
+19.59% | 323B | |
+4.89% | 287B | |
+14.32% | 235B | |
+5.79% | 199B | |
-9.49% | 195B | |
+4.26% | 161B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Shanghai Fosun Pharmaceutical : Fosun Pharma Wins Nod to Market Lymphoma Drug in China; Shares Jump 6% in Hong Kong